Evidence map›Paper›PMID 42589154›Full record

ArticleBiology2026

A Bioinformatics Analysis Based on Omics and Clinical Data for Graph-Based Patient Stratification in Hepatocellular Carcinoma.

Paolo Pio Bevilacqua, Paola Paci, Giulia Fiscon

Abstract read
In one paragraph

Article in Biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paolo Pio BevilacquaDepartment of Computer Science, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0009-0001-3988-0119
Paola PaciDepartment of Computer, Control and Management Engineering, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-9393-2047
Giulia FisconInstitute for Systems Analysis and Computer Science "Antonio Ruberti", National Research Council, 00185 Rome, Italy.ORCID 0000-0002-3354-8203

Funding

Finalizzata Giovani Ricercatori 2021 B83C22007560001Finalizzata Giovani Ricercatori 2021 GR-2021-12372614Sapienza Project "Progetti Ateneo Medi" 2024 RM1241910FFBE448
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is one of the most frequent and lethal malignancies worldwide, with substantial molecular and clinical heterogeneity that complicates prognostic assessment. We aimed to identify molecular subgroups with distinct prognostic profiles using a graph-based multi-omics approach. Similarity Network Fusion (SNF) was applied to integrate mRNA and miRNA sequencing data from the TCGA-LIHC cohort (366 patients), and spectral clustering on the fused similarity network was used to identify patient subgroups. Survival differences were assessed by log-rank test and Cox regression; subgroup characterisation combined direction-aware over-representation analysis and one-versus-all differential expression. Six clusters with distinct survival trajectories were identified in the discovery cohort (exploratory log-rank

Indexed as

disease subtypinghepatocellular carcinomamiRNAmulti-omics integrationpatient stratificationprecision medicinesimilarity network fusiontranscriptomics

Identifiers

PMID42589154
PMCPMC13465779

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.